Sphingosylphosphorylcholine Promotes Th9 Cell Differentiation Through Regulation of Smad3, STAT5, and β-Catenin Pathways

키워드

참고문헌 (59)

1. Schmitt E, "IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma", J Immunol, 153, pp.3989~3996 (1994)
2. Veldhoen M, "Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset", Nat Immunol, 9, pp.1341~1346 (2008)
3. Dardalhon V, "IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3-effector T cells", Nat Immunol, 9, pp.1347~1355 (2008)
4. Jones CP, "Activin A and TGF-β promote TH9 cell-mediated pulmonary allergic pathology", J Allergy Clin Immunol, 129, pp.1000~1010 (2012)
5. Xue G, "IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling", Nat Commun, 10, pp.1376~ (2019)
6. Wong MT, "Regulation of human Th9 differentiation by type I interferons and IL-21", Immunol Cell Biol, 88, pp.624~631 (2010)
7. Végran F, "The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells", Nat Immunol, 15, pp.758~766 (2014)
8. Angkasekwinai P, "Regulation of IL-9 expression by IL-25 signaling", Nat Immunol, 11, pp.250~256 (2010)
9. Yao W, "Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP", Immunity, 38, pp.360~372 (2013)
10. Jiang Y, "TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways", J Immunother Cancer, 7, pp.28~ (2019)
11. Xiao X, "OX40 signaling favors the induction of TH9 cells and airway inflammation", Nat Immunol, 13, pp.981~990 (2012)
12. Richard AC, "The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells", J Immunol, 194, pp.3567~3582 (2015)
13. Kim IK, "Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells", Nat Med, 21, pp.1010~1017 (2015)
14. Xiao X, "GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation", Nat Commun, 6, pp.8266~ (2015)
15. Tamiya T, "Smad2", 3 and IRF4 play a cooperative role in IL-9-producing T cell induction, 2013, pp.191, 2360~2371
16. Staudt V, "Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells", Immunity, 33, pp.192~202 (2010)
17. Chang HC, "The transcription factor PU. 1 is required for the development of IL-9-producing T cells and allergic inflammation", Nat Immunol, 11, pp.527~534 (2010)
18. Malik S, "Transcription factor Foxo1 is essential for IL-9 induction in T helper cells", Nat Commun, 8, pp.815~ (2017)
19. Licona-Limón P, "Th9 cells drive host immunity against gastrointestinal worm infection", Immunity, 39, pp.744~757 (2013)
20. Purwar R, "Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells", Nat Med, 18, pp.1248~1253 (2012)
21. Lu Y, "Th9 cells represent a unique subset of CD4+ T cells endowed with the ability to eradicate advanced tumors", Cancer Cell, 33, pp.1048~1060 (2018)
22. Hara J, "High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis", J Invest Dermatol, 115, pp.406~413 (2000)
23. Rodriguez-Lafrasse C, "Sphingosylphosphorylcholine in Niemann-Pick disease brain : accumulation in type A but not in type B", Neurochem Res, 24, pp.199~205 (1999)
24. El-Najjar N, "Increased levels of sphingosylphosphorylcholine(SPC)in plasma of metabolic syndrome patients", PLoS One, 10, pp.e0140683~ (2015)
25. Xu Y, "Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients", Clin Cancer Res, 1, pp.1223~1232 (1995)
26. Okamoto R, "Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis", J Lipid Res, 44, pp.93~102 (2003)
27. Kim HJ, "Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632", Eur J Pharmacol, 583, pp.92~96 (2008)
28. Andoh T, "Leukotriene B4 mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin", J Invest Dermatol, 129, pp.2854~2860 (2009)
29. Brandt EB, "Th2 cytokines and atopic dermatitis", J Clin Cell Immunol, 2, pp.110~ (2011)
30. Ma L, "Possible pathogenic role of T helper type 9 cells and interleukin(IL)-9 in atopic dermatitis", Clin Exp Immunol, 175, pp.25~31 (2014)
31. Mizutani H, "Serum IL-21 levels are elevated in atopic dermatitis patients with acute skin lesions", Allergol Int, 66, pp.440~444 (2017)
32. Jensen AO, "Atopic dermatitis and risk of skin cancer : a Danish nationwide cohort study(1977-2006)", Am J Clin Dermatol, 13, pp.29~36 (2012)
33. Marasigan V, "Inverse association between atopy and melanoma : a case-control study", Acta Derm Venereol, 97, pp.54~57 (2017)
34. Yue HW, "Sphingosylphosphorylcholine in cancer progress", Int J Clin Exp Med, 8, pp.11913~11921 (2015)
35. Hou F, "Distinct transcriptional and functional differences of lung resident and monocyte-derived alveolar macrophages during the recovery period of acute lung injury", Immune Netw, 23, pp.e24~ (2023)
36. Byun DJ, "NLRP3 exacerbate NETosis-associated neuroinflammation in an LPS-induced inflamed brain", Immune Netw, 23, pp.e27~ (2023)
37. Tan C, "Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site", J Immunol, 185, pp.6795~6801 (2010)
38. Schlapbach C, "Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity", Sci Transl Med, 6, pp.219~ (2014)
39. Ishii I, "Lysophospholipid receptors : signaling and biology", Annu Rev Biochem, 73, pp.321~354 (2004)
40. Jeon ES, "Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism", J Cell Sci, 119, pp.4994~5005 (2006)
41. Fortunel NO, "Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis", Blood, 96, pp.2022~2036 (2000)
42. Ogawa K, "Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages", J Immunol, 177, pp.6787~6794 (2006)
43. Ulrich BJ, "STAT3 activation impairs the stability of Th9 cells", J Immunol, 198, pp.2302~2309 (2017)
44. Yang CY, "The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets", Nat Immunol, 12, pp.1221~1229 (2011)
45. Gattinoni L, "Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells", Nat Med, 15, pp.808~813 (2009)
46. Kaminski MM, "Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression : mechanism of ciprofloxacin-mediated immunosuppression", J Immunol, 184, pp.4827~4841 (2010)
47. Sena LA, "Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling", Immunity, 38, pp.225~236 (2013)
48. Rao VR, "Mitochondrial-targeted antioxidants attenuate TGF-β2 signaling in human trabecular meshwork cells", Invest Ophthalmol Vis Sci, 60, pp.3613~3624 (2019)
49. Hamanaka RB, "Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development", Sci Signal, 6, pp.ra8~ (2013)
50. Lu Y, "The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation", J Biol Chem, 287, pp.41014~41022 (2012)
51. Li WQ, "Transforming growth factor β1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species", Free Radic Biol Med, 37, pp.196~207 (2004)
52. Son Y, "Reactive oxygen species in the activation of MAP kinases", Methods Enzymol, 528, pp.27~48 (2013)
53. Restifo NP, "Adoptive immunotherapy for cancer : harnessing the T cell response", Nat Rev Immunol, 12, pp.269~281 (2012)
54. Gattinoni L, "Adoptive immunotherapy for cancer : building on success", Nat Rev Immunol, 6, pp.383~393 (2006)
55. Klebanoff CA, "IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells", Proc Natl Acad Sci U S A, 101, pp.1969~1974 (2004)
56. Hinrichs CS, "IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy", Blood, 111, pp.5326~5333 (2008)
57. Lu Y, "Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers", Proc Natl Acad Sci U S A, 111, pp.2265~2270 (2014)
58. Liu L, "Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9", Nat Commun, 11, pp.5902~ (2020)
59. Imokawa G, "Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes", J Invest Dermatol, 112, pp.91~96 (1999)

관련 논문AI추천